BioCatalyst

infigratinib 0.128 mg/kg/day, infigratinib 0.25 mg/kg/day — catalyst calendar

1 verified catalyst event(s) referencing infigratinib 0.128 mg/kg/day, infigratinib 0.25 mg/kg/day, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01 (month)
in 3mo
ESTIMATED
 READOUT
An Interventional Study of Infigratinib in Children With Hypochondroplasia
Phase 2/3 · Hypochondroplasia
 QED Therapeutics, a BridgeBio comp infigratinib 0.128 mg/kg/day, infigratin ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.